SBIR-STTR Award

Biologically-Derived Targeted Antifungals for Textile Applications
Award last edited on: 8/22/2018

Sponsored Program
SBIR
Awarding Agency
DOD : Army
Total Award Amount
$566,623
Award Phase
2
Solicitation Topic Code
A17-018
Principal Investigator
Greg Bertsch

Company Information

Antimicrobial Materials Inc

5201 South Sweetbriar Court
Sioux Falls, SD 57108
   (605) 366-4749
   info@amibrilliant.com
   www.amibrilliant.com
Location: Single
Congr. District: 00
County: Lincoln

Phase I

Contract Number: W911NF-17-P-0049
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2017
Phase I Amount
$99,992
Fungal skin infections plague active duty servicemembers at elevated rates due to exposure to warm, humid climates, poor skin hygiene, and close-quarters living arrangements. We have developed a novel solution that incorporates a endophytic fungal extract with selective activity against Trichophyton species of pathogens. In addition, the selected compound has negligible impact on the organisms that natural inhabit skin. This approach offers the potential for effective control of fungal skin pathogens while preserving benefits of a healthy skin microbiome, and limiting the development of resistant organisms. In a secondary invention, the compound will be incorporated into common-use textiles for apparel applications and other uses.

Phase II

Contract Number: W911NF-18-C-0073
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
Phase II Amount
$466,631
Fungal skin infections plague active duty servicemembers at elevated rates due to exposure to warm, humid climates, poor skin hygiene, and close-quarters living arrangements. We have developed a novel solution that incorporates an endophytic fungal extract with selective activity against Trichophyton species of pathogens. In addition, the selected compound has negligible impact on the organisms that natural inhabit skin. This approach offers the potential for effective control of fungal skin pathogens while preserving benefits of a healthy skin microbiome, and limiting the development of resistant organisms.Our phase I effort successfully demonstrated proof of concept for incorporation of the compound onto fabrics.In phase II, we will refine the design and complete testing of antifungal fabric performance, durability, and safety.In addition, we will optimize the manufacturing process for large-scale production.